Designed for success – new SNA vaccine proves highly effective in mice - European Pharmaceutical Review

Scientists have developed a spherical nucleic acid (SNA) vaccine showing promise as a COVID-19 therapy, as well as an anti-cancer treatment.

Posted: 6 April 2022 | Mandy Parrett (European Pharmaceutical Review) | No comments yet A team of scientists has developed a spherical nucleic acid (SNA) vaccine, which has demonstrated high efficac… [+3052 chars]

full article...